Search Results
9 results found for "nevada"
- Nevada Adds New Syringe Exchange Vending Machines, Building on Success
Just before the holiday, the Southern Nevada Health District (SNHD) announced it would be showcasing has chosen to invest in successes already achieved and expand their vending machine program.In 2017, Nevada Nevada’s syringe change program is operated by Trac-B Exchange out of a store front and the entity was With nearly ten percent of Nevada’s new HIV diagnoses being attributed to illicit syringe use and the Since the 2017 pilot launch in Nevada, other jurisdictions have considered beginning their own programs
- Hepatitis C Medicaid Access Dashboard Provides 2023 Updates
states remaining with this policy), six states having removed substance use restrictions, one state (Nevada
- HRSA Tightens STI Clinic 340B Rules Amid Industry Lawsuit
The companies specifically challenge Nevada-based Sagebrush Health Services, where discounts totaled
- Healthcare Infrastructure Crisis Compounds America's STI Epidemic
funding specifically intended to expand Disease Intervention Specialist capacity, with states like Nevada
- HIV/HCV Co-Infection Watch Q1: January 2026
began offering HCV treatment for the first time with ribavirin, Mavyret, Pegasys, and generic Epclusa; Nevada Nevada substantially reduced its HCV formulary by removing Sovaldi, Harvoni, Zepatier, Vosevi, and generic
- HIV/HCV Co-Infection Watch Q2: April 2026
began offering HCV treatment for the first time with ribavirin, Mavyret, Pegasys, and generic Epclusa; Nevada Nevada substantially reduced its HCV formulary by removing Sovaldi, Harvoni, Zepatier, Vosevi, and generic
- HIV/HCV Co-Infection Watch Q4: October 2025
began offering HCV treatment for the first time with ribavirin, Mavyret, Pegasys, and generic Epclusa; Nevada Nevada substantially reduced its HCV formulary by removing Sovaldi, Harvoni, Zepatier, Vosevi, and generic
- HIV/HCV Co-Infection Watch Q3: July 2025
began offering HCV treatment for the first time with ribavirin, Mavyret, Pegasys, and generic Epclusa; Nevada Nevada substantially reduced its HCV formulary by removing Sovaldi, Harvoni, Zepatier, Vosevi, and generic
- HIV/HCV Co-Infection Watch Q4: October 2023
a Unified Medicaid Formulary Ohio – Ohio has a Unified Medicaid Formulary that applies to all MCOs Nevada






